News

New drug a breakthrough for cystic fibrosis patients

New drug a breakthrough for cystic fibrosis patients

Source: Seattle Times

A new drug, Kalydeco, is the first medication that targets the genetic cause of cystic fibrosis, not just its symptoms. Kalydeco was recently approved by the FDA after a key trial led by Dr. Bonnie Ramsey of Seattle Children’s Research Institute showed striking results.